Blood-grouping reagents market in Germany

Earlier Report Observations

From 2018 to 2019, production of blood-grouping reagents in Germany increased from 653.1 million USD to 672.3 million USD, while the market size grew from 623.5 million USD to 638.9 million USD. This growth was supported by the German Medical Association updating blood collection guidelines to reflect medical advances and a published statement on pathogen inactivation systems for platelet concentrates, which reinforced product safety standards. Additionally, rising numbers of traffic accidents with severe injuries in regions like India and China were identified as a factor boosting global demand for blood-typing reagents.

The upward trend continued through 2020, with production reaching 702.9 million USD and market size 674.1 million USD. In 2021, a sharp expansion occurred, as production jumped to 870.2 million USD and the market size to 834.3 million USD.

In the later years of the period, regulatory developments further shaped the market environment. In March 2023, an amendment to the Transfusion Act introduced individual risk assessment for blood donations based on sexual behavior, and the Haemotherapy Guidelines were revised to implement new legal frameworks. During 2024, new directives for blood and plasma products were approved to improve quality and safety standards, a model working instruction for erythrocyte concentrate transfusions was adopted, and research into new blood group systems and conversion techniques advanced, pointing to potential future innovations.

Production blood-grouping reagents in Germany

In value, 2017-2020, M $ US

Germany's production of blood-grouping reagents has increased for the third consecutive year. In 2020, output reached 702.9 million US dollars, marking a modest 4.6% rise compared to the previous year. Over the period from 2017 to 2020, production grew by 25.6%, with a compound annual growth rate of 7.9%.

Annual dynamics of production in Germany in value, 2017-2020, M $ US

Exports blood-grouping reagents from Germany

Exports in kind, t

Germany's exports of blood-grouping reagents have declined for the third year in a row. In 2020, exports totaled 211.2 tonnes, reflecting a significant 15.5% decrease from 2019. Between 2017 and 2020, exports fell by 33.1%, which translates to an annualized decline of 12.5%.

Annual dynamics of product's exports from Germany in kind, 2017-2020, t

From 2017 to 2020, Italy, the United Kingdom, and the United States were among the largest buyers of blood-grouping reagents from Germany, accounting for 19.0%, 13.8%, and 12.8% of exports in kind, respectively. However, even combined, these three countries represented just 45.5% of total exports, indicating a broadly diversified partner base.

Structure of product's exports in kind by countries, 2017-2020

World map of product's exports from Germany in kind, 2017-2020

Exports in value, K $ US

Germany's exports of blood-grouping reagents have decreased for the third consecutive year. In 2020, export value amounted to 58 199 thousand US dollars, corresponding to a 5.7% drop compared to the previous year. Between 2017 and 2020, exports declined by 11.3%, with an annualized rate of 3.9%.

Annual dynamics of product's exports from Germany in value, 2017-2020, K $ US

Between 2017 and 2020, Germany traded blood-grouping reagents with numerous countries. Even the largest destinations—the United States, Italy, and the United Kingdom—together accounted for only 49.3% of total exports in value terms.

Structure of product's exports in value by countries, 2017-2020

World map of product's exports from Germany in value, 2017-2020

Imports blood-grouping reagents to Germany

Imports in kind, t

In 2020, Germany's imports of blood-grouping reagents reached 316.1 tonnes, showing a slight 0.7% increase over the previous year. Over the period from 2017 to 2020, imports decreased by 7.6%, with a compound annual growth rate of -2.6%. The lowest import volume was recorded in 2019 at 313.9 tonnes, while the highest was in 2018 at 350.8 tonnes. The largest decline occurred in 2019 with a 10.5% drop, and the largest increase was in 2018 with a 2.6% rise.

Annual dynamics of product's imports to Germany in kind, 2017-2020, t

From 2017 to 2020, Switzerland and the United States consistently made up 89.6% of Germany's total imports of blood-grouping reagents in kind. This high concentration is accompanied by a long tail of smaller markets.

Structure of product's imports in kind by countries, 2017-2020

World map of product's imports to Germany in kind, 2017-2020

Imports in value, K $ US

After a two-year decline, Germany's imports of blood-grouping reagents increased in 2020. The country imported approximately 29 355 thousand US dollars worth of these reagents, up by 4.0% compared to the previous year. Over the period from 2017 to 2020, imports fell by 22.9%, with a compound annual growth rate of -8.3%. The lowest import value was recorded in 2019 at 28 219 thousand US dollars, and the largest decline occurred that same year with a 20.8% drop.

Annual dynamics of product's imports to Germany in value, 2017-2020, K $ US

Between 2017 and 2020, the United States and Switzerland were the leading sources for Germany's imports of blood-grouping reagents in value terms, together accounting for 82.0% of total flows. The remaining share was distributed among other countries.

Structure of product's imports in value by countries, 2017-2020

World map of product's imports to Germany in value, 2017-2020